API | coagulation factor viia (recombinant)

coagulation factor viia (recombinant) (NovoSevenRT) Report issue

Biologics Recombinant protein Orphan Drug ^FDA Approved ^FDA

AACT ChEMBL DrugBank Drug Central MeSH repoDB

Active Ingredient History

NOW

Now

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules:

eptacog alfa (activated)

eptacog alfa

More Chemistry

Pharmacology

Mechanisms of Action:
- Coagulation factor VII (Homo sapiens) ^UniProt
- Coagulation factor VII (Homo sapiens) ^UniProt
Multi-specific: No
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

coagulation factor viia | coagulation factor viia (recombinant) | coagulation factor viia recombinant human | eptacog alfa | eptacog alfa (activated) | factor viia | novoseven | novo seven | recombinant coagulation factor viia | recombinant factor viia | recombinant fviia | recombinant human factor viia | rfviia | rviia-fp

Organizations (46)

Research & Development (46)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (2)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (25)

Approved Indications (2)

Hemophilia A (approved 1999)

Hemophilia B (approved 1999)

Experimental Indications - Clinical Trial Phases 1-4 (25)

Blood Coagulation (Phase 1)

Blood Coagulation Disorders (Phase 3)

Burns (Phase 3)

Cerebral Hemorrhage (Phase 3)

Coronary Artery Disease (Phase 3)

Cystitis (Phase 2)

Deficiency Diseases (Phase 1)

Dengue Virus (Phase 2)

Factor VII Deficiency (Phase 3)

Factor VIII (Phase 4)

Fibrosis (Phase 2)

General Surgery (Phase 3)

Healthy Volunteers (Phase 1)

Heart Valve Diseases (Phase 3)

Hemophilia A (Phase 4)

Hemophilia B (Phase 4)

Hemorrhage (Phase 3)

Hemorrhagic Disorders (Phase 1)

Hemostasis (Phase 2)

Intracranial Hemorrhages (Phase 1)

Myocardial Ischemia (Phase 3)

Postpartum Hemorrhage (Phase 4)

Spinal Fusion (Phase 2)

Stroke (Phase 2)

Wounds and Injuries (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 73
# of Trial Organizations: 46

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue